Michael Douglas Taylor, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 14,896 shares at $43.94 ($655K) on 2021-03-01, disclosed to the SEC on 2021-03-03.
Open-market sale of $655k DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.94 | 6,896 | $303K | 46.2% |
| 2 | $43.94 | 6,896 | $303K | 46.2% |
| 3 | $44.68 | 1,104 | $49K | 7.5% |
| Total | $43.99 avg | 14,896 | $655K | 100% |
| Filing → |
| DCPH | SELL | 2021-02-03 | $687K | — | Filing → |
| DCPH | SELL | 2021-01-06 | $2.1M | — | Filing → |
| DCPH | SELL | 2020-12-03 | $2.3M | — | Filing → |